BRIEF published on 06/06/2024 at 16:52, 2 years 4 months ago Tribeca Lawsuit Loans Expands Services to Provide Litigation Loans for Appeals Cases Financial Support Litigation Loans Legal Funding Appealed Cases Non-recourse Loans
BRIEF published on 06/06/2024 at 16:52, 2 years 4 months ago Tribeca Lawsuit Loans étend ses services pour fournir des prêts de litige pour les affaires d'appel Aide Financière Prêts Pour Litiges Financement Juridique Affaires Faisant Appel Prêts Sans Recours
BRIEF published on 06/06/2024 at 16:50, 2 years 4 months ago Soditech annonce la mise à disposition des documents préparatoires à l'AGM 2024 Actionnaires Assemblée Générale Documents Préparatoires SODITECH Cannes La Bocca
BRIEF published on 06/06/2024 at 16:50, 2 years 4 months ago Soditech announces the availability of preparatory documents for the 2024 AGM Shareholders General Assembly Preparatory Documents SODITECH Cannes La Bocca
BRIEF published on 06/06/2024 at 16:50, 2 years 4 months ago Pearl Certification to Incorporate New National Definition of a Zero-Emissions Building Energy Efficiency U.S. Department Of Energy Pearl Certification Zero-emissions Home Certification
BRIEF published on 06/06/2024 at 16:50, 2 years 4 months ago La certification Pearl intégrera la nouvelle définition nationale d'un bâtiment à zéro émission Efficacité Énergétique Certification Perle Département Américain De L'énergie Zéro Émission Accueil Certification
BRIEF published on 06/06/2024 at 16:35, 2 years 4 months ago Hardman Talks Video | Chesnara plc (CSN) Management Presentation and Q&A Financial Results Hardman & Co M&A Dividend Growth Chesnara Plc
BRIEF published on 06/06/2024 at 16:35, 2 years 4 months ago Hardman parle vidéo | Chesnara plc (CSN) Présentation de la direction et questions-réponses Résultats Financiers Fusions Et Acquisitions Hardman & Cie Croissance Des Dividendes Chesnara SA
BRIEF published on 06/06/2024 at 16:35, 2 years 4 months ago Outlook Therapeutics Receives European Authorization for LYTENAVA™ JTC Team Outlook Therapeutics LYTENAVA™ European Authorization Wet AMD
BRIEF published on 06/06/2024 at 16:35, 2 years 4 months ago Outlook Therapeutics reçoit l'autorisation européenne pour LYTENAVA™ LYTENAVA™ Perspectives Thérapeutiques Autorisation Européenne L'équipe JTC DMLA Humide
Published on 11/04/2026 at 23:10, 4 hours 14 minutes ago Ur-Energy Announces Date for Third Quarter 2026 Results and Conference Call and Webcast
Published on 11/04/2026 at 23:00, 4 hours 24 minutes ago Viemed Healthcare Announces Third Quarter 2026 Financial Results
Published on 11/04/2026 at 22:15, 5 hours 9 minutes ago Zomedica Announces Record Third Quarter Revenue of $9.9 Million, Up 22% Year-Over-Year, Net Loss Reduced 48%, with $41 Million in Liquidity
Published on 11/04/2026 at 22:05, 5 hours 19 minutes ago Stabilis Solutions Announces Third Quarter 2026 Results
Published on 11/05/2026 at 03:10, 14 minutes ago SensAI Veritas Launches SensAI Gateway™ and SensAI Helm™: Bringing Risk Intelligence to the Moment of Trust
Published on 11/05/2026 at 00:02, 3 hours 21 minutes ago EQS-Adhoc: NEXTDC Limited: Response to Share Raid by Goodman Group and Digital Realty
Published on 11/04/2026 at 19:41, 7 hours 43 minutes ago EQS-Adhoc: SNP SE Raises Outlook for the Full Year 2026
Published on 11/04/2026 at 19:25, 7 hours 59 minutes ago Menarini Group and Ryvu Therapeutics Announce First Clinical Data from the Phase II JASPIS-01 Study of dapolsertib (MEN1703, SEL24) in Heavily Pretreated Relapsed/Refractory Aggressive B-cell non-Hodgkin Lymphoma at the 2026 ASH Annual Meeting
Published on 11/04/2026 at 18:43, 8 hours 41 minutes ago EQS-Adhoc: Deutsche EuroShop refines its revenue forecast and raises its earnings forecast for the 2026 financial year
Published on 11/04/2026 at 18:00, 9 hours 24 minutes ago The Belgian State and Engie Group have agreed to extend the target date for concluding the Heads of Terms until 12 December 2026
Published on 11/04/2026 at 18:00, 9 hours 24 minutes ago L’État belge et le groupe ENGIE ont convenu de se donner un délai supplémentaire jusqu’au 12 décembre 2026 pour la conclusion des Heads of Terms
Published on 11/04/2026 at 17:44, 9 hours 40 minutes ago Aéroports de Paris SA - Information regarding the voting rights and shares as of 31 October 2026
